Press Archive
- Charles Francis: Weakening eye surgery laws places WV patients in jeopardy
- Mark D. Mayle, MD - 2022 Secretariat Award Recipients
- Dr. Larry Schwab recognized with 2020 International Blindness Prevention Award
- Wow Moment with Joseph A. LoCasio | Bio-Tissue | #WowWednesdays
- WVU Today | Moore, Oppe named recipients of Heebink award for Distinguished Service
- Cornea Transplant Restores Young Boy’s Sight After Fishing Accident
- Keep your eyes healthy and safe in the workplace
- Glaucoma Awareness Month
- Ophthalmologists Say 90 Percent of Work-Related Eye Injuries Can be Avoided by Wearing Eye Protection
- Five Tips to Avoid Toy-Related Eye Injuries
- Details
To assess the incidence, risk factors, and impact of age on retinal detachment (RD) after cataract surgery.
- Details
Distinguishing between vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC) can be challenging. Historically, AKC is rarely recognized as a diagnostic entity before puberty and is thought to occur predominantly in adults. If a young patient were to present with AKC-like symptoms and atopic dermatitis, they might be diagnosed with VKC.1 The aim of this report was to establish guidelines for distinguishing diagnosis between AKC and VKC.
Read more: Atopic Keratoconjunctivitis in Children: Clinical Features and Diagnosis
- Details
News about untreatable sight loss is devastating. Clinicians have an important role to play in determining when and how information is provided, gauging how effectively patients are likely to cope, and recognizing when someone needs to access treatment for their psychological distress. It is true that some resilient individuals are able to adjust, eventually, to their new situation, but many others find the myriad of practical problems associated with sight loss and worry about the future overwhelming, their psychological well-being suffers, and many sink into chronic depression.
Read more: High Prevalence of Untreated Depression in Patients Accessing Low-Vision Services
- Details
To investigate the effect of prior intravitreal anti–vascular endothelial growth factor (VEGF) injections on surgical and postoperative complication rates associated with cataract surgery in a nationally representative longitudinal sample of elderly persons.
- Details
Nonsyndromic myopia is increasing in frequency throughout the world, particularly high myopia (≥−6.0 diopters [D]), which is more associated with complications such as chorioretinal atrophy and retinal detachment.1 Although high myopia is sometimes clearly familial, only a limited number of genes have been associated with monogenic nonsyndromic myopia to date. Those associated with autosomal dominant nonsyndromic high myopia include zinc finger protein 644 (Online Mendelian Inheritance in Man [OMIM] *614159, ZNF644), SCO2 cytochrome c oxidase assembly protein (OMIM *604272, SCO2), solute carrier family 39 zinc carrier member 5 (OMIM *608730, SLC39A5), procollagen proline 2-oxoglutarate-4-dioxygenase alpha subunit isoform 2 (OMIM *600608, P4HA2), and coiled coil containing domain 111 (OMIM *615421, CCDC111).
Read more: Clinical Characterization of -Related Pediatric High Myopia
- Details
Ocular surface squamous neoplasia (OSSN) represents a spectrum of diseases ranging from mild dysplasia to invasive squamous cell carcinoma. Ocular surface squamous neoplasia can be successfully managed with surgical excision or medical therapy. Interferon-α-2b (IFNα-2b) treatment recently has been established as a standard treatment option for OSSN, eliminating the need for surgical excision. However, approximately 15% of tumors do not respond to IFNα-2b therapy.1 It remains unclear which tumor-specific factors may affect treatment response or course after treatment.
Read more: Whole Exome Profiling of Ocular Surface Squamous Neoplasia